|
|
Article: Genomic effects of stimulated bone estrogen receptors determined.
- Article from:
- Clinical Oncology Week
- Article date:
- August 16, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 AUG 16 - (NewsRx.com & NewsRx.net) -- The genomic effects of stimulated bone estrogen receptors in osteosarcoma have been determined.
"Estrogens exert many important effects in bone, a tissue that contains both estrogen receptors alpha and beta (ERalpha and ERbeta)," endocrinologists in the United States explained.
"To compare the actions of these receptors," F. Stossi and colleagues at the University of Illinois "generated U2OS human osteosarcoma cells stably expressing ERalpha or ERbeta, at levels comparable with those in osteoblasts," and "characterized their response to 17beta-estradiol (E2) over time using Affymetrix GeneChip microarrays to ...